Repression of Gadd45alpha by activated FLT3 and GM-CSF receptor mutants contributes to growth, survival and blocked

M Perugini1, C H Kok, A L Brown

  • 1Division of Haematology, Institute of Medical and Veterinary Science, Hanson Institute, Adelaide, South Australia, Australia.

Leukemia
|January 20, 2009
PubMed

Insights

The tumor suppressor Gadd45alpha is downregulated in acute myeloid leukemia (AML) due to sustained receptor signaling, promoting cancer growth and survival. Restoring Gadd45alpha levels inhibits AML cell proliferation and induces differentiation.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Signaling

Background:

  • Gadd45alpha, a tumor suppressor, is a known repressed target of sustained ERK1/2 signaling.
  • Constitutive signaling from FLT3 mutants (FLT3-ITD, FLT3-TKD) and a GM-CSF receptor mutant (GMR-V449E) are common in AML.
  • GADD45A mRNA downregulation correlates with FLT3-ITD(+) AML.

Purpose of the Study:

  • To investigate the role of Gadd45alpha downregulation in AML pathogenesis.
  • To determine the impact of sustained receptor signaling on Gadd45alpha expression.
  • To evaluate the therapeutic potential of restoring Gadd45alpha function in AML.

Main Methods:

  • Analyzing Gadd45alpha gene expression in AML cell lines with specific receptor mutants.
  • Utilizing shRNA to knockdown Gadd45alpha and assessing effects on cell growth and survival.
  • Enforcing Gadd45alpha expression and observing its impact on cell viability, apoptosis, and differentiation.

Main Results:

  • Sustained ERK1/2 signaling significantly downregulates Gadd45alpha mRNA in cells with activated receptor mutants.
  • Gadd45alpha knockdown enhances FDB1 cell growth and survival.
  • Gadd45alpha overexpression reduces growth and viability in FLT3-ITD and GMR-V449E expressing cells, inducing apoptosis and cell cycle arrest.
  • Gadd45alpha overexpression in GMR-V449E cells promotes myeloid differentiation, suggesting its downregulation maintains a differentiation block.

Conclusions:

  • ERK1/2-mediated Gadd45alpha downregulation by sustained receptor signaling is a key mechanism driving AML growth, survival, and blocked differentiation.
  • Restoring Gadd45alpha function presents a potential therapeutic strategy for AML.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...